China SXT Pharmaceuticals, Inc.
SXTC
$0.09
-$0.01-5.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -31.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -31.25% | |||
| Cost of Revenue | 0.00% | -22.69% | |||
| Gross Profit | 0.00% | -56.23% | |||
| SG&A Expenses | 0.00% | 183.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 135.83% | |||
| Operating Income | 0.00% | -210.40% | |||
| Income Before Tax | 0.00% | -154.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -154.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -154.65% | |||
| EBIT | 0.00% | -210.40% | |||
| EBITDA | 0.00% | -210.92% | |||
| EPS Basic | 0.00% | 94.65% | |||
| Normalized Basic EPS | 0.00% | 94.63% | |||
| EPS Diluted | 0.00% | 94.65% | |||
| Normalized Diluted EPS | 0.00% | 94.63% | |||
| Average Basic Shares Outstanding | 0.00% | 4,649.98% | |||
| Average Diluted Shares Outstanding | 0.00% | 4,649.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||